To evaluate the health and environmental impacts of the EAT-Lancet diet, a measurable way to assess adherence was needed. We created a scoring system that translates the Commission’s recommendations into a tool for population-based research.
This EAT-Lancet diet has been shown to lower the risk of:
Mortality
Heart failure
Atrial fibrillation
Diabetes
Steatotic liver disease
Dementia
We have also seen that it does not increase the risk of micronutrient deficiencies.
We have seen an association with lower greenhouse gas emissions. Our work demonstrates that the EAT-Lancet diet can deliver clear co-benefits for human health and the planet.
Our work puts the EAT-Lancet recommendations into practice by creating a method to measure dietary adherence in real populations. This has allowed us to build robust evidence on links between diet, health, and sustainability. Progress indicators include:
Development and international uptake of the scoring system
Peer-reviewed publications on mortality, chronic disease, and micronutrient adequacy
Ongoing comparisons of scoring methods to improve validity and harmonization
Researchers: develop, test, and refine scoring systems, and assess links with health and environmental outcomes.
Public health professionals & policymakers: translate findings into practical guidelines and recommendations.
General population: the ultimate end-users of dietary guidance, who benefit from clear and simple assessments and communication.
Expand research across diverse populations to test generalizability.
Examine potential trade-offs between short-term nutrient adequacy and long-term disease prevention.
Collaborate internationally to harmonize adherence scores and enhance policy relevance.
Translate findings into dietary guidelines and sustainability strategies aligned with the SDGs.
Consistent, pre-defined scoring systems are essential for comparability across studies. Scoring should be determined a priori, not adapted to fit results.
Sustainable diets provide co-benefits for both health and the environment.
For more information contact: Anna Stubbendorff at Anna.Stubbendorff@med.lu.se